Glycan-Targeted RNA Delivery

Sugar Code × RNA

Engineering glycan ligands that guide RNA therapeutics to the cells that need them most — unlocking precision delivery for the next generation of medicines.

Scroll
Architecture

Three layers, one system

Every glycan-targeted therapeutic is built from three concentric components — each computationally optimized.

Glycan-Targeted Delivery

Sugar Code × RNA

Every tissue has its own code. We computationally engineer glycan ligands as molecular addresses — directing RNA therapeutics to specific cells with unprecedented precision.

Three layers, one system: a glycan targeting ligand, a presentation motif, and an RNA therapeutic core — assembled into programmable medicines.

Cell Type
Macrophages
B Cells
T Cells
Tissue
Lungs
Liver
Brain
Vasculature
Immune
Tumors
0+Virtual glycans screened
0Tissue targets
0+Novel binders discovered
0%Hit rate simulation to binder
The Immune Arsenal

Cells that defend us

Each cell type plays a unique role in the immune response. Understanding them is the key to engineering targeted delivery.

Macrophage

Macrophage

First responder. Engulfs pathogens and debris.

T Cell

T Cell

Adaptive killer. Targets infected cells with precision.

Natural Killer Cell

Natural Killer Cell

Innate assassin. Destroys without prior activation.

Neutrophil

Neutrophil

Rapid deployer. First to arrive at infection sites.

Dendritic Cell

Dendritic Cell

Master presenter. Bridges innate and adaptive immunity.

Eosinophil

Eosinophil

Parasite hunter. Releases toxic granules on contact.

Mast Cell

Mast Cell

Sentinel. Triggers inflammation and allergic response.

Monocyte

Monocyte

Circulating precursor. Differentiates into macrophages.

Blood Cells

Blood Cells

The full ecosystem. Red cells, white cells, platelets.

The future of drug delivery is written in sugar

CellCo is building the computational platform to decode, design, and deploy glycan-targeted therapeutics at scale.